blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3781128

EP3781128 - COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.01.2023
Database last updated on 24.08.2024
FormerRequest for examination was made
Status updated on  22.01.2021
FormerThe international publication has been made
Status updated on  25.10.2019
Most recent event   Tooltip13.01.2023Application deemed to be withdrawnpublished on 15.02.2023  [2023/07]
Applicant(s)For all designated states
Alsar Ltd Partnership
8251 W. Broward Blvd. Suite 102
Plantation FL 33324 / US
[2021/08]
Inventor(s)01 / FISHEL, Robert
102 Basin Drive
Delray Beach, Florida 33483 / US
 [2021/08]
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[2021/08]
Application number, filing date19788399.416.04.2019
[2021/08]
WO2019US27706
Priority number, dateUS201862657947P16.04.2018         Original published format: US 201862657947 P
[2021/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019204326
Date:24.10.2019
Language:EN
[2019/43]
Type: A1 Application with search report 
No.:EP3781128
Date:24.02.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 24.10.2019 takes the place of the publication of the European patent application.
[2021/08]
Search report(s)International search report - published on:US24.10.2019
(Supplementary) European search report - dispatched on:EP07.02.2022
ClassificationIPC:A61K9/24, A61K31/138, A61K31/4458, A61P9/06, A61K45/06
[2022/10]
CPC:
A61K9/209 (EP); A61K31/4458 (EP,US); A61K31/138 (EP,US);
A61K45/06 (EP); A61K9/4808 (US); A61P9/06 (EP)
C-Set:
A61K31/138, A61K2300/00 (EP);
A61K31/4458, A61K2300/00 (EP)
Former IPC [2021/08]A61K9/00, A61M11/00, A61P9/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/08]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERZÖGERTEN FREISETZUNG VON FLECAINID[2021/08]
English:COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE[2021/08]
French:COMPOSITIONS ET PROCÉDÉS POUR LA LIBÉRATION PROLONGÉE DE FLÉCAÏNIDE[2021/08]
Entry into regional phase22.10.2020National basic fee paid 
22.10.2020Search fee paid 
22.10.2020Designation fee(s) paid 
22.10.2020Examination fee paid 
Examination procedure22.10.2020Examination requested  [2021/08]
07.09.2022Application deemed to be withdrawn, date of legal effect  [2023/07]
27.09.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/07]
Fees paidRenewal fee
05.02.2021Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.202204   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2011098194  (LICONSA LABORATORIOS SA [ES], et al) [X] 1-4 * page 1, lines 6-27 * * page 4, lines 23-32 * * page 6, lines 9-19 * * page 12, line 24 - page 13, line 24 * * example - * * claim - *;
 [XI]US6087394  (DUHAYLONGSOD FRANCIS G [US]) [X] 3,5 * column 5, lines 39-49 * * column 12, lines 11-60 * * column 16, lines 6-25 * [I] 4;
 [X]WO2007103557  (RELIANT PHARMACEUTICALS INC [US], et al) [X] 3,5-7 * page 8, paragraph 0025 * * pages 15-17, paragraph 0044 * * page 28, paragraph 0072 - page 32, paragraph 0084 * * example 1 * * claim - *;
 [X]WO2008063323  (RELIANT PHARMACEUTICALS INC [US], et al) [X] 3,5-11 * page 13, paragraph 0031 - page 14, paragraph 0032 * * page 27, paragraph 0070 - page 30, paragraph 0075 * * page 30, paragraph 0076 * * pages 32-33, paragraph 0084 * * claim - *
International search[XY]WO2011098194  (LICONSA LABORATORIOS SA [ES], et al) [X] 1-2 * ; entire document, especially abstract, pg 1 lines 17-27, pg 4 lines 24-27, pg 13 lines 20-24 * [Y] 4;
 [XY]US6087394  (DUHAYLONGSOD FRANCIS G [US]) [X] 3, 5 * ; entire document, especially abstract, col 12 lines 41-58, col 16 lines 5-25 * [Y] 4;
 [A]US2016158213  (MOUTHON FRANCK [FR], et al) [A] 1-5 * ; entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.